Litigators of the Week: The Plaintiffs’ Team Behind the $1.6B Essure Settlement Bayer AG last week announced a proposed $1.6 billion deal to settle U.S. claims involving the birth control implant Essure, which plaintiffs claimed caused side effects including hair and tooth loss, bleeding, chronic pelvic pain, miscarriages and death for those implanted with the…
Firm Partner Erin Copeland Helps Lead Essure Lawsuit to Victory as a Lead Member of the JCCP Executive Committee On Thursday, Bayer announced it was settling the long-standing Essure® litigation for $1.6 billion. Attorney Erin Copeland has been a lead member of the court-appointed Plaintiffs’ Executive Committee for the Essure® JCCP pending in Oakland, California,…
One day following the protest by Essure victims outside its corporate offices, Bayer, one of the leading pharmaceutical companies in the world, has announced that it will stop selling its Essure birth control device by the end of 2018. Essure has long been accused of triggering severe health complications in women, including but not limited to chronic…
Erin Copeland, attorney and partner at Fibich, Leebron, Copeland & Briggs, will be a guest speaker at the upcoming HB Litigation Conferences 3-day event, Mass Tort Med School + Class Actions, in Orlando, Florida on March 16. Erin will discuss litigation surrounding Essure®, which is a permanent contraceptive medical device that has been the subject of…
Partner Erin Copeland of Fibich, Leebron, Copeland & Briggs has been invited to speak at the Masters of Mass Tort legal conference taking place this week. Erin, along with other industry leaders from around the country, will come together to discuss topics unique to mass torts, including currently pending litigation. Erin will be speaking on…
Attorney Erin Copeland, partner of Fibich, Leebron, Copeland & Briggs has recently been appointed to the Essure Executive Committee for California as a Judicial Council Coordinate Proceeding (JCCP). Erin has been a prominent leader in the fight against Essure and often speaks out about the dangers of this risky medical device. Essure is a birth control device made out…
Fibich, Leebron, Copeland & Briggs along with a team of other product liability firms recently obtained a remand of their Essure medical device cases back to a St. Louis, Missouri state court. Essure is a method of permanent birth control that has come under fire for the number of safety concerns raised by patients and cited in…
Testing Essure is marketed as a form of permanent birth control device made of metals, including nickel and titanium. The device consists of two coils that are implanted into a woman’s fallopian tubes and are intended to remain there for the life of the patient blocking sperm from reaching the eggs. A number of risks have…
According to a new press release, a judge in California has ordered all cases in the state against Bayer Corporation regarding the Essure® permanent birth control device be consolidated before a single judge in the Alameda County Superior Court. The plaintiffs in the litigation are represented by a team of national leaders in the fight against…
Many women who were implanted with the Essure® permanent birth control device have complained of painful and severe adverse events that required the women to have the device surgically removed. The Essure® device has been marketed as a non-incisional alternative to other permanent birth control surgical procedures, such as vasectomy and tubal ligation. Two Essure®…
